MORE►
Pharmaceutical
[Image: McKesson]
‘As the Industry Evolves, So Do We’: McKesson Launches Rapid Returns Solution for Health Systems
by Quincy Preston | Sep 16, 2021
McKesson is streamlining the return of unsaleable drugs to reduce the burden on health systems. It can also increase their profitability.
The offering is powered by a national pharmaceutical reverse logistics and disposal provider, Pharmalink.
by Quincy Preston |
Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE►
by Natalie Le |
May 28, 2019
The women-owned technology company—dubbed the "eharmony of the pharmaceutical industry"—is making it easier for life science professionals to connect with leading industry players such as AstraZeneca, Roche, Genentech in minutes.
MORE►
by Lance Murray |
May 22, 2019
The clinical-stage oncology company develops small molecule drugs to treat kidney cancer and other diseases. Its renal cell carcinoma drug is in a Phase II clinical trial.
MORE►
Lantern Pharma's drug development efforts are led by biotechnology scientist and entrepreneur Dr. Arun Asaithambi. [Photo: Courtesy of Lantern Pharma]
Cancer-Fighting Dallas Pharma Raises $3.7M
by Amy Wolff Sorter | May 5, 2017
Dallas-based Lantern Pharma is a clinical stage biotech company pioneering in the field of precision oncology.
MORE►
by Julia Batlle |
Apr 12, 2017
Art Clapp is continuing his pharmaceutical endeavors with a new product from his company, NuvoThera.
MORE►
